Carolien Eggermont

1PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 15, 2022
The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer.

Carolien Eggermont, Philippe Giron, Maxim Noeparast

Pageof 1

Frequent Collaborators

1 joint publications

Jacques De Grève